Elting LS - Search Results

1

Medical futility and appropriate medical care in patients whose death is thought to be imminent.

Escalante CP, Martin CG, Elting LS, Rubenstein EB. Escalante CP, et al. Among authors: elting ls. Support Care Cancer. 1997 Jul;5(4):274-80. doi: 10.1007/s005200050074. Support Care Cancer. 1997. PMID: 9257423 Review.

2

Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis.

Avritscher EB, Cantor SB, Shih YC, Escalante CP, Rivera E, Elting LS. Avritscher EB, et al. Among authors: elting ls. Support Care Cancer. 2004 Jul;12(7):531-6. doi: 10.1007/s00520-004-0597-2. Epub 2004 Feb 21. Support Care Cancer. 2004. PMID: 14986076

3

Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.

Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Escalante CP, et al. Among authors: elting ls. Cancer. 1996 Sep 15;78(6):1314-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2. Cancer. 1996. PMID: 8826956

4

Controversies in new antibiotic therapy for ambulatory patients.

Sundararajan V, Rubenstein EB, Rolston KV, Elting LS. Sundararajan V, et al. Among authors: elting ls. Support Care Cancer. 1997 Sep;5(5):358-64. doi: 10.1007/s005200050092. Support Care Cancer. 1997. PMID: 9322346 Review.

5

Identifying risk factors for imminent death in cancer patients with acute dyspnea.

Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Escalante CP, et al. Among authors: elting ls. J Pain Symptom Manage. 2000 Nov;20(5):318-25. doi: 10.1016/s0885-3924(00)00193-7. J Pain Symptom Manage. 2000. PMID: 11068153 Free article.

6

Ambulatory management of varicella-zoster virus infection in immunocompromised cancer patients.

Rolston KV, Manzullo E, Elting L, Frisbee-Hume S, Rodriguez S, Rubenstein EB. Rolston KV, et al. Support Care Cancer. 1998 Jan;6(1):57-62. doi: 10.1007/s005200050133. Support Care Cancer. 1998. PMID: 9458538 Clinical Trial.

7

The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.

Elting LS, Martin CG, Kurtin DJ, Cantor SB, Rubenstein EB, Rodriguez S, Kanesan K, Vadhan-Raj S, Benjamin RS. Elting LS, et al. Cancer. 2002 Jun 15;94(12):3252-62. doi: 10.1002/cncr.10603. Cancer. 2002. PMID: 12115358 Free article.

8

Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors.

Elting LS, Cantor SB, Martin CG, Hamblin L, Kurtin D, Rivera E, Vadhan-Raj S, Benjamin RS. Elting LS, et al. Cancer. 2003 Mar 15;97(6):1541-50. doi: 10.1002/cncr.11195. Cancer. 2003. PMID: 12627519 Free article.

9

Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.

Cantor SB, Elting LS, Hudson DV Jr, Rubenstein EB. Cantor SB, et al. Among authors: elting ls. Cancer. 2003 Jun 15;97(12):3099-106. doi: 10.1002/cncr.11447. Cancer. 2003. PMID: 12784347 Free article.

10

Measuring chemotherapy-induced nausea and emesis.

Martin CG, Rubenstein EB, Elting LS, Kim YJ, Osoba D. Martin CG, et al. Among authors: elting ls. Cancer. 2003 Aug 1;98(3):645-55. doi: 10.1002/cncr.11540. Cancer. 2003. PMID: 12879484 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters